Debojit Bose
Debojit Bose
Shape Therapeutics
Verified email at shapetx.com
Title
Cited by
Cited by
Year
The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR‐21 function by directly targeting its precursor
D Bose, G Jayaraj, H Suryawanshi, P Agarwala, SK Pore, R Banerjee, ...
Angewandte Chemie 124 (4), 1043-1047, 2012
1672012
High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase
MA Ditzler, MJ Lange, D Bose, CA Bottoms, KF Virkler, AW Sawyer, ...
Nucleic acids research 41 (3), 1873-1884, 2013
572013
A molecular-beacon-based screen for small molecule inhibitors of miRNA maturation
D Bose, GG Jayaraj, S Kumar, S Maiti
ACS chemical biology 8 (5), 930-938, 2013
522013
An RNA-based fluorescent biosensor for high-throughput analysis of the cGAS-cGAMP-STING pathway
D Bose, Y Su, A Marcus, DH Raulet, MC Hammond
Cell chemical biology 23 (12), 1539-1549, 2016
472016
Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates
MA Ditzler, D Bose, N Shkriabai, B Marchand, SG Sarafianos, ...
Nucleic acids research 39 (18), 8237-8247, 2011
462011
Selective inhibition of miR-21 by phage display screened peptide
D Bose, S Nahar, MK Rai, A Ray, K Chakraborty, S Maiti
Nucleic acids research 43 (8), 4342-4352, 2015
392015
cGAS/STING pathway in cancer: Jekyll and Hyde story of cancer immune response
D Bose
International journal of molecular sciences 18 (11), 2456, 2017
352017
Anti-cancer therapeutic potential of quinazoline based small molecules via global upregulation of miRNAs
SK Panja
Chemical communications 50 (35), 4639-4642, 2014
192014
Dynamic regulation of tRNA modifications in cancer
P Close, D Bose, A Chariot, SA Leidel
Cancer and noncoding RNAs, 163-186, 2018
92018
Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin
S Kumar, D Bose, H Suryawanshi, H Sabharwal, K Mapa, S Maiti
PLoS One 6 (8), e23300, 2011
92011
Differential Interleukin-2 transcription kinetics render mouse but not human T cells vulnerable to splicing inhibition early after activation
D Bose, A Neumann, B Timmermann, S Meinke, F Heyd
Molecular and cellular biology 39 (16), e00035-19, 2019
52019
Aminoglycoside antibiotics perturb physiologically important microRNA contributing to drug toxicity
GG Jayaraj, S Ramasamy, D Bose, H Suryawanshi, M Lalwani, ...
bioRxiv, 137935, 2017
22017
Cyclic cationic peptides containing sugar amino acids selectively distinguishes and inhibits maturation of pre-miRNAs of the same family
S Nahar, D Bose, S Pal, TK Chakraborty, S Maiti
nucleic acid therapeutics 25 (6), 323-329, 2015
22015
Compositions and methods for genome editing
D Bose
US Patent App. WO2021/242870 A1, 2021
2021
Compositions and methods for modifying target rnas
D Bose, A Briggs, B Booth, D Huss, Y Savva, R Sullivan
US Patent App. WO2021/242903A2, 2021
2021
FLUORESCENT BIOSENSOR FOR 2 ' , 3' - cGAMP
M Hammond, Y Su, D Bose
US Patent US 2019 / 0161754 A1, 2019
2019
Streptomycin, an inhibitor of miR-21 reduces invasion and suppresses tumor growth
SK Pore, D Bose, S Maiti, R Banerjee
NISCAIR-CSIR, India, 2015
2015
Down regulation of Oncogenic MiRNAs by small molecules
B Debojit
Pune, 0
The system can't perform the operation now. Try again later.
Articles 1–18